CAP-TB News

18 April, 2017
Although tuberculosis (TB) cases and deaths declined significantly between 2011 and 2015, one subpopulation of patients is being hit harder by TB infections more than ever. Individuals living with HIV showed a 40% increase in coinfection with TB over the same study period. In a public statement on... Read more
10 April, 2017
Tuberculosis, once better known as consumption for the way its victims wasted away, has a long and deadly history, with estimates indicating it may have killed more people than any other bacterial pathogen. Consumption played a role in many of our stories of the Old West, but even today — despite $... Read more
10 April, 2017
A new KTP Associate, Joseph Canyelles Pericas (Pep), will be working at the Redcar-based company over the next two years on a disposable TB kit for use in the developing world. The Knowledge Transfer Partnership, run by Innovate UK, the Government’s Innovation Agency, not only provides Epigem with... Read more
5 April, 2017
Scientists from LSTM's Research Centre for Drugs and Diagnostics (RCDD) have described in a paper published today in Scientific Reports, a new way of screening potential treatments for Tuberculosis (TB) which may assist in the identification and prioritisation of new therapies which could... Read more
5 April, 2017
Today, World TB Day, sees the launch of the PLOS Tuberculosis Channel: https://channels.plos.org/tuberculosis Channels are resources for communities: a single destination that features curated content selected from PLOS journals as well as the broader literature, supplemented by commentary, blogs,... Read more
27 March, 2017
A new quantitative method to estimate annual incidence of tuberculosis (TB) in India by the Ministry of Health and Family Welfare has depicted a clear urban rural divide for the infectious disease. The method revealed that while TB infects more individuals per year in urban centres, rural TB cases... Read more
27 March, 2017
GENEVA - New tuberculosis (TB) ethics guidance, launched today by the World Health Organization (WHO), aims to help ensure that countries implementing the End TB Strategy adhere to sound ethical standards to protect the rights of all those affected. TB, the world’s top infectious disease killer,... Read more
21 March, 2017
India among other countries in the South East Asian Region, which bear half of the global tuberculosis burden, today signed a 'call for action' and pledged to scale up measures to end the disease by 2030. India reports 2.8 million new TB cases annually and nearly half a million deaths due to the... Read more
10 March, 2017
Tuberculosis (TB) killed more people in 2015 than any other single infectious agent, but funding for research to develop better prevention, diagnosis, and treatment methods for TB declined to its lowest level in 7 years. TB research and development (R&D) is woefully underfunded, a situation... Read more
10 March, 2017
Médecins Sans Frontières (MSF), Partners In Health and Interactive Research & Development have launched a major clinical trial which seeks to revolutionise treatment for the toughest strains of tuberculosis (TB), the world’s leading infectious disease killer. The first patient started... Read more
4 March, 2017
A new research has found that antibacterial compounds present in soil can lead to a new horizon in the treatment of tuberculosis. The research has been initiated by a team from the University of Sydney, Australia. According to Medical Xpress, tuberculosis is the cause of more deaths than any other... Read more
22 February, 2017
Tuberculosis, the world’s leading infectious killer, may have finally met its match. Two new drug therapies may be able to cure all forms of tuberculosis – even the ones most difficult to treat. Together, the new treatments, called BPaMZ and BPaL, could make treating TB much simpler and more... Read more
22 February, 2017
A simple blood test commonly used in screening adults for tuberculosis could predict whether children infected with the TB bacteria are likely to progress to the active disease, according to a study by researchers at the Stanford University School of Medicine and five other institutions. In an... Read more
8 February, 2017
Researchers at the University of Southampton have developed a new 3D system to study human infection in the laboratory. The team, which includes infection researchers, engineers and bioinformaticians in Southampton and University College London, have used an electrostatic encapsulation technique... Read more
8 February, 2017
Last year I met Saw Robert, a bus driver from Myanmar undergoing treatment for multiple-drug resistant tuberculosis (MDR-TB), at a Médecins Sans Frontières clinic in Yangon. Not only did the 43-year-old have a resistant form of TB which is difficult to treat, with severe side effects for patients... Read more
6 February, 2017
While city-based TB survivor Marzia Dalal applauded the government move to finally focus on the dreaded disease and end it, doctors are a tad sceptical. “Eliminating TB by 2025 is a pipe dream. It is just too optimistic,” said Dr Zarir Udwadia, consulting chest physician who was the first in the... Read more
6 February, 2017
In 2010, the TB Alliance received a grant from the United States Food and Drug Administration to establish a Consortium for Tuberculosis Biomarkers (CTB2), comprised of the TB Alliance, CDC's TB Trials Consortium (TBTC), and NIAID's AIDS Clinical Trials Group (ACTG). By collecting high-quality... Read more
6 February, 2017
TB Alliance will provide pretomanid, a drug in the final stages of clinical development, as well as its drug development expertise as a partner on a clinical trial launched by Médecins Sans Frontières/ Doctors Without Borders (MSF). The study, TB PRACTECAL, a composite Phase II-III trial which... Read more
30 January, 2017
Taking a new approach toward tuberculosis therapy, a UCLA-led research team has devised a potential drug regimen that could cut the treatment time by up to 75 percent, while simultaneously reducing the risk that patients could develop drug-resistant TB.Read the full article here: https://... Read more
30 January, 2017
Switzerland - IOM, with financial support from the Stop TB Partnership, launched the world’s first dedicated TB and Migration Portal: The Knowledge Platform on Tuberculosis and Migration (tbandmigration.iom.int). The portal, created by IOM’s Migration Health Division (MHD), aims to offer a... Read more

Pages